カテゴリー： QYResearch, 世界

世界のMEK阻害剤産業：成長傾向・競合分析2019-2025

【英語タイトル】Global MEK Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料（DATA909X01476）・商品コード：DATA909X01476
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートでは、世界のMEK阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。MEK阻害剤の種類別には、メキニスト、コテリック、メクトビに、用途別には、NSCLC、がんに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・MEK阻害剤の種類別市場規模：メキニスト、コテリック、メクトビ
・MEK阻害剤の用途別市場規模：NSCLC、がん
・MEK阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La Roche Ltd.、Novartis AG、Ono Pharmaceutical Co. Ltd.、Pfizer Inc.
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.In 2018, the global MEK Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for MEK Inhibitors.

This study researches the market size of MEK Inhibitors, presents the global MEK Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of MEK Inhibitors in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of MEK Inhibitors for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
F. Hoffmann-La Roche Ltd.
Novartis AG
Ono Pharmaceutical Co. Ltd.
Pfizer Inc.
…

Market Segment by Product Type
MEKINIST
COTELLIC
MEKTOVI

Market Segment by Application
NSCLC
Cancer

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global MEK Inhibitors status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key MEK Inhibitors manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of MEK Inhibitors are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global MEK Inhibitors Market Size Growth Rate by Type
1.3.2 MEKINIST
1.3.3 COTELLIC
1.3.4 MEKTOVI
1.4 Market Segment by Application
1.4.1 Global MEK Inhibitors Market Share by Application (2019-2025)
1.4.2 NSCLC
1.4.3 Cancer
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global MEK Inhibitors Market Size
2.1.1 Global MEK Inhibitors Revenue 2014-2025
2.1.2 Global MEK Inhibitors Sales 2014-2025
2.2 MEK Inhibitors Growth Rate by Regions
2.2.1 Global MEK Inhibitors Sales by Regions 2014-2019
2.2.2 Global MEK Inhibitors Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 MEK Inhibitors Sales by Manufacturers
3.1.1 MEK Inhibitors Sales by Manufacturers 2014-2019
3.1.2 MEK Inhibitors Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 MEK Inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 MEK Inhibitors Revenue Share by Manufacturers (2014-2019)
3.2.3 Global MEK Inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 MEK Inhibitors Price by Manufacturers
3.4 Key Manufacturers MEK Inhibitors Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into MEK Inhibitors Market
3.6 Key Manufacturers MEK Inhibitors Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 MEKINIST Sales and Revenue (2014-2019)
4.1.2 COTELLIC Sales and Revenue (2014-2019)
4.1.3 MEKTOVI Sales and Revenue (2014-2019)
4.2 Global MEK Inhibitors Sales Market Share by Type
4.3 Global MEK Inhibitors Revenue Market Share by Type
4.4 MEK Inhibitors Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global MEK Inhibitors Sales by Application

6 North America
6.1 North America MEK Inhibitors Breakdown Data by Company
6.2 North America MEK Inhibitors Breakdown Data by Type
6.3 North America MEK Inhibitors Breakdown Data by Application
6.4 North America MEK Inhibitors Breakdown Data by Countries
6.4.1 North America MEK Inhibitors Sales by Countries
6.4.2 North America MEK Inhibitors Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe MEK Inhibitors Breakdown Data by Company
7.2 Europe MEK Inhibitors Breakdown Data by Type
7.3 Europe MEK Inhibitors Breakdown Data by Application
7.4 Europe MEK Inhibitors Breakdown Data by Countries
7.4.1 Europe MEK Inhibitors Sales by Countries
7.4.2 Europe MEK Inhibitors Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific MEK Inhibitors Breakdown Data by Company
8.2 Asia Pacific MEK Inhibitors Breakdown Data by Type
8.3 Asia Pacific MEK Inhibitors Breakdown Data by Application
8.4 Asia Pacific MEK Inhibitors Breakdown Data by Regions
8.4.1 Asia Pacific MEK Inhibitors Sales by Countries
8.4.2 Asia Pacific MEK Inhibitors Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India

9 Central & South America
9.1 Central & South America MEK Inhibitors Breakdown Data by Company
9.2 Central & South America MEK Inhibitors Breakdown Data by Type
9.3 Central & South America MEK Inhibitors Breakdown Data by Application
9.4 Central & South America MEK Inhibitors Breakdown Data by Countries
9.4.1 Central & South America MEK Inhibitors Sales by Countries
9.4.2 Central & South America MEK Inhibitors Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa MEK Inhibitors Breakdown Data by Type
10.2 Middle East and Africa MEK Inhibitors Breakdown Data by Application
10.3 Middle East and Africa MEK Inhibitors Breakdown Data by Countries
10.3.1 Middle East and Africa MEK Inhibitors Sales by Countries
10.3.2 Middle East and Africa MEK Inhibitors Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of MEK Inhibitors
11.1.4 MEK Inhibitors Product Introduction
11.1.5 AstraZeneca Plc Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of MEK Inhibitors
11.2.4 MEK Inhibitors Product Introduction
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of MEK Inhibitors
11.3.4 MEK Inhibitors Product Introduction
11.3.5 Novartis AG Recent Development
11.4 Ono Pharmaceutical Co. Ltd.
11.4.1 Ono Pharmaceutical Co. Ltd. Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of MEK Inhibitors
11.4.4 MEK Inhibitors Product Introduction
11.4.5 Ono Pharmaceutical Co. Ltd. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of MEK Inhibitors
11.5.4 MEK Inhibitors Product Introduction
11.5.5 Pfizer Inc. Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 MEK Inhibitors Sales Channels
12.2.2 MEK Inhibitors Distributors
12.3 MEK Inhibitors Customers

13 Market Forecast
13.1 Global MEK Inhibitors Sales and Revenue Forecast 2019-2025
13.2 Global MEK Inhibitors Sales Forecast by Type
13.3 Global MEK Inhibitors Sales Forecast by Application
13.4 MEK Inhibitors Forecast by Regions
13.4.1 Global MEK Inhibitors Sales Forecast by Regions 2019-2025
13.4.2 Global MEK Inhibitors Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America MEK Inhibitors Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe MEK Inhibitors Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific MEK Inhibitors Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.8 Central & South America Market Forecast
13.8.1 Central & South America MEK Inhibitors Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa MEK Inhibitors Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure MEK Inhibitors Product Picture
Table MEK Inhibitors Key Market Segments
Table Major Manufacturers MEK Inhibitors Covered in This Report
Table Global MEK Inhibitors Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global MEK Inhibitors Sales Market Shar by Type 2014-2025
Figure MEKINIST Figures
Table Major Manufacturers of MEKINIST
Figure COTELLIC Figures
Table Major Manufacturers of COTELLIC
Figure MEKTOVI Figures
Table Major Manufacturers of MEKTOVI
Table Global MEK Inhibitors Market Share by Application 2019-2025 (K Units)
Figure NSCLC Use Case
Figure Cancer Use Case
Figure MEK Inhibitors Report Years Considered
Figure Global MEK Inhibitors Market Size 2014-2025 (Million US$)
Figure Global MEK Inhibitors Sales 2014-2019 (K Units)
Table Global MEK Inhibitors Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global MEK Inhibitors Sales by Regions 2014-2019 (K Units)
Table Global MEK Inhibitors Sales Market Share by Regions 2014-2019
Figure Global MEK Inhibitors Sales Market Share by Regions 2014-2019
Figure Global MEK Inhibitors Sales Market Share by Regions in 2018
Table Global MEK Inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global MEK Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global MEK Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global MEK Inhibitors Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global MEK Inhibitors Sales by Manufacturers (2014-2019) (K Units)
Table Global MEK Inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global MEK Inhibitors Sales Share by Manufacturers in 2018
Table MEK Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table MEK Inhibitors Revenue Share by Manufacturers (2014-2019)
Figure MEK Inhibitors Value Share by Manufacturers in 2018
Table Global MEK Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers MEK Inhibitors Price (2014-2019) (USD/Unit)
Table Key Manufacturers MEK Inhibitors Plants/Factories Distribution
Table Key Manufacturers MEK Inhibitors Area Served
Table Date of Key Manufacturers Enter into MEK Inhibitors Market
Table Key Manufacturers MEK Inhibitors Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global MEKINIST Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global COTELLIC Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global MEKTOVI Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global MEK Inhibitors Sales by Type (2014-2019) (K Units)
Table Global MEK Inhibitors Sales Share by Type (2014-2019)
Figure Global MEK Inhibitors Sales Market Share by Type (2014-2019)
Figure Global MEK Inhibitors Sales Market Share by Type in 2018
Table Global MEK Inhibitors Revenue by Type (2014-2019) (Million US$)
Table Global MEK Inhibitors Revenue Share by Type (2014-2019)
Figure Global MEK Inhibitors Revenue Market Share by Type (2014-2019)
Figure Global MEK Inhibitors Revenue Market Share by Type in 2018
Table MEK Inhibitors Price by Type 2014-2019 (USD/Unit)
Table Global MEK Inhibitors Sales by Application (2014-2019) (K Units)
Table Global MEK Inhibitors Sales Share by Application (2014-2019)
Figure Global Sales MEK Inhibitors Market Share by Application (2014-2019)
Figure Global Sales MEK Inhibitors Market Share by Application in 2018
Figure North America MEK Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure North America MEK Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America MEK Inhibitors Sales by Company (2014-2019) (K Units)
Table North America MEK Inhibitors Sales Market Share by Company (2014-2019)
Figure North America MEK Inhibitors Sales Market Share by Company in 2018
Table North America MEK Inhibitors Sales by Type (2014-2019) (K Units)
Table North America MEK Inhibitors Sales Market Share by Type (2014-2019)
Figure North America MEK Inhibitors Market Share by Type in 2018
Table North America MEK Inhibitors Sales by Application (2014-2019) (K Units)
Table North America MEK Inhibitors Sales Market Share by Application (2014-2019)
Figure North America MEK Inhibitors Market Share by Application in 2018
Table North America MEK Inhibitors Sales by Countries (2014-2019) (K Units)
Table North America MEK Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America MEK Inhibitors Sales Market Share by Countries in 2018
Table North America MEK Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America MEK Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America MEK Inhibitors Revenue Market Share by Countries in 2018
Figure United States MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Canada MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Mexico MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Europe MEK Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Europe MEK Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe MEK Inhibitors Sales by Company (2014-2019) (K Units)
Table Europe MEK Inhibitors Sales Market Share by Company (2014-2019)
Figure Europe MEK Inhibitors Sales Market Share by Company in 2018
Table Europe MEK Inhibitors Sales by Type (2014-2019) (K Units)
Table Europe MEK Inhibitors Sales Market Share by Type (2014-2019)
Figure Europe MEK Inhibitors Sales Market Share by Type in 2018
Table Europe MEK Inhibitors Sales by Application (2014-2019) (K Units)
Table Europe MEK Inhibitors Sales Market Share by Application (2014-2019)
Figure Europe MEK Inhibitors Sales Market Share by Application in 2018
Table Europe MEK Inhibitors Sales by Countries (2014-2019) (K Units)
Table Europe MEK Inhibitors Sales Market Share by Countries (2014-2019)
Figure Europe MEK Inhibitors Sales Market Share by Countries in 2018
Table Europe MEK Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe MEK Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe MEK Inhibitors Revenue Market Share by Countries in 2018
Figure Germany MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure France MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure UK MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Italy MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Russia MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific MEK Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific MEK Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific MEK Inhibitors Sales by Regions (2014-2019) (K Units)
Table Asia Pacific MEK Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific MEK Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific MEK Inhibitors Sales by Type (2014-2019) (K Units)
Table Asia Pacific MEK Inhibitors Sales Market Share by Type (2014-2019)
Figure Asia Pacific MEK Inhibitors Market Share by Type in 2018
Table Asia Pacific MEK Inhibitors Sales by Application (2014-2019) (K Units)
Table Asia Pacific MEK Inhibitors Sales Market Share by Application (2014-2019)
Figure Asia Pacific MEK Inhibitors Market Share by Application in 2018
Table Asia Pacific MEK Inhibitors Sales by Countries (2014-2019) (K Units)
Table Asia Pacific MEK Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific MEK Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific MEK Inhibitors Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific MEK Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific MEK Inhibitors Revenue Market Share by Regions in 2018
Figure China MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure China MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Japan MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Korea MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure India MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Australia MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Philippines MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Thailand MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam MEK Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America MEK Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America MEK Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America MEK Inhibitors Sales by Company (2014-2019) (K Units)
Table Central & South America MEK Inhibitors Sales Market Share by Company (2014-2019)
Figure Central & South America MEK Inhibitors Sales Market Share by Company in 2018
Table Central & South America MEK Inhibitors Sales by Type (2014-2019) (K Units)
Table Central & South America MEK Inhibitors Sales Market Share by Type (2014-2019)
Figure Central & South America MEK Inhibitors Market Share by Type in 2018
Table Central & South America MEK Inhibitors Sales by Application (2014-2019) (K Units)
Table Central & South America MEK Inhibitors Sales Market Share by Application (2014-2019)
Figure Central & South America MEK Inhibitors Market Share by Application in 2018
Table Central & South America MEK Inhibitors Sales by Countries (2014-2019) (K Units)
Table Central & South America MEK Inhibitors Sales Market Share by Countries (2014-2019)
Figure Central & South America MEK Inhibitors Sales Market Share by Countries in 2018
Table Central & South America MEK Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America MEK Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Central & South America MEK Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Brazil MEK Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa MEK Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa MEK Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa MEK Inhibitors Sales by Type (2014-2019) (K Units)
Table Middle East and Africa MEK Inhibitors Sales Market Share by Type (2014-2019)
Figure Middle East and Africa MEK Inhibitors Sales Market Share by Type in 2018
Table Middle East and Africa MEK Inhibitors Sales by Application (2014-2019) (K Units)
Table Middle East and Africa MEK Inhibitors Sales Market Share by Application (2014-2019)
Figure Middle East and Africa MEK Inhibitors Sales Market Share by Application in 2018
Table Middle East and Africa MEK Inhibitors Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa MEK Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa MEK Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa MEK Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa MEK Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa MEK Inhibitors Revenue Market Share by Countries in 2018
Figure GCC Countries MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries MEK Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Egypt MEK Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa MEK Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure South Africa MEK Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Table AstraZeneca Plc Company Details
Table AstraZeneca Plc Description and Business Overview
Table AstraZeneca Plc MEK Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Plc MEK Inhibitors Sales Growth Rate (2014-2019)
Table AstraZeneca Plc MEK Inhibitors Sales Market Share in Global Market
Table AstraZeneca Plc Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Description and Business Overview
Table F. Hoffmann-La Roche Ltd. MEK Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. MEK Inhibitors Sales Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. MEK Inhibitors Sales Market Share in Global Market
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG MEK Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG MEK Inhibitors Sales Growth Rate (2014-2019)
Table Novartis AG MEK Inhibitors Sales Market Share in Global Market
Table Novartis AG Recent Development
Table Ono Pharmaceutical Co. Ltd. Company Details
Table Ono Pharmaceutical Co. Ltd. Description and Business Overview
Table Ono Pharmaceutical Co. Ltd. MEK Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ono Pharmaceutical Co. Ltd. MEK Inhibitors Sales Growth Rate (2014-2019)
Table Ono Pharmaceutical Co. Ltd. MEK Inhibitors Sales Market Share in Global Market
Table Ono Pharmaceutical Co. Ltd. Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Description and Business Overview
Table Pfizer Inc. MEK Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. MEK Inhibitors Sales Growth Rate (2014-2019)
Table Pfizer Inc. MEK Inhibitors Sales Market Share in Global Market
Table Pfizer Inc. Recent Development
Figure MEK Inhibitors Value Chain
Table MEK Inhibitors Distributors List
Table MEK Inhibitors Customers List
Table Global MEK Inhibitors Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Global MEK Inhibitors Revenue Forecast 2019-2025 (Million US$)
Table Global MEK Inhibitors Sales Forecast by Type 2019-2025 (K Units)
Figure Global MEK Inhibitors Sales Forecast by Type 2019-2025 (K Units)
Figure Global MEK Inhibitors Sales Market Share Forecast by Type 2019-2025
Table Global MEK Inhibitors Sales Forecast by Application 2019-2025 (K Units)
Figure Global MEK Inhibitors Sales Forecast by Application 2019-2025 (K Units)
Figure Global MEK Inhibitors Sales Market Share Forecast by Application 2019-2025
Table Global MEK Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Figure Global MEK Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Figure Global MEK Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global MEK Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global MEK Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global MEK Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table North America MEK Inhibitors Sales Forecast by Countries 2019-2025 (K Units)
Table North America MEK Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table North America MEK Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America MEK Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure United States MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Canada MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Mexico MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Table Europe MEK Inhibitors Sales Forecast by Countries 2019-2025 (K Units)
Table Europe MEK Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Europe MEK Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe MEK Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Germany MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure France MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure UK MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Italy MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Russia MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Table Asia Pacific MEK Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific MEK Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific MEK Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific MEK Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure China MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Japan MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure South Korea MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure India MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Table Central & South America MEK Inhibitors Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America MEK Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Central & South America MEK Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America MEK Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa MEK Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa MEK Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa MEK Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa MEK Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure GCC Countries MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Egypt MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Figure South Africa MEK Inhibitors Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AstraZeneca Plc、F. Hoffmann-La Roche Ltd.、Novartis AG、Ono Pharmaceutical Co. Ltd.、Pfizer Inc.

★調査レポート[世界のMEK阻害剤産業：成長傾向・競合分析2019-2025] (コード：DATA909X01476)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のMEK阻害剤産業：成長傾向・競合分析2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のBRAFキナーゼ阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X00353 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のBRAFキナーゼ阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。BRAFキナーゼ阻害剤の種類別には、ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブに、用途別には、病院、医学研究所、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・BRAFキナーゼ阻害剤の種類別市場規模：ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブ ・BRAFキナーゼ阻害剤の用途別市場規模：病院、医学研究所、クリニック、その他 ・BRAFキナーゼ阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Array BioPharma Inc.、Bayer...BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period. In 2018, the global BRAF Kinase Inhibitors market size was xx million US$ and...
  • 世界のヤヌスキナーゼ（JAK）阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01275 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のヤヌスキナーゼ（JAK）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ヤヌスキナーゼ（JAK）阻害剤の種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ヤヌスキナーゼ（JAK）阻害剤の種類別市場規模：自己免疫疾患、腫瘍学 ・ヤヌスキナーゼ（JAK）阻害剤の用途別市場規模：クリニック、病院 ・ヤヌスキナーゼ（JAK）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Astellas Pharma, Inc.、Eli...Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Janus Kinase (JAK) Inhibitors. This study researches the market...
  • 世界のホスホジエステラーゼ（PDE）阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01764 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のホスホジエステラーゼ（PDE）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ホスホジエステラーゼ（PDE）阻害剤の種類別には、PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤に、用途別には、経口、局所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ホスホジエステラーゼ（PDE）阻害剤の種類別市場規模：PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤 ・ホスホジエステラーゼ（PDE）阻害剤の用途別市場規模：経口、局所、その他 ・ホスホジエステラーゼ（PDE）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Bayer AG、Eli Lilly...A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s). PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period. In 2018, the global Phosphodiesterase (PDE) inhibitors market size was xx million US$ and is forecast...
  • 世界の有毛細胞白血病治療産業：成長傾向・競合分析2019-2025
    DATA909X01057 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の有毛細胞白血病治療市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。有毛細胞白血病治療の種類別には、化学療法薬、標的阻害剤に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・有毛細胞白血病治療の種類別市場規模：化学療法薬、標的阻害剤 ・有毛細胞白血病治療の用途別市場規模：クリニック、病院 ・有毛細胞白血病治療の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia.In 2018, the global Hairy Cell Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hairy Cell Leukemia Drugs. This study researches the market size of Hairy Cell Leukemia Drugs, presents the global Hairy Cell Leukemia Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界の皮膚炎薬産業：成長傾向・競合分析2019-2025
    DATA909X00652 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の皮膚炎薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。皮膚炎薬の種類別には、カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他に、用途別には、病院薬局、小売薬局、オンライン薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・皮膚炎薬の種類別市場規模：カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他 ・皮膚炎薬の用途別市場規模：病院薬局、小売薬局、オンライン薬局 ・皮膚炎薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Regeneron、Bausch Health、Astellas Pharma、Pfizer、Mylan、Bayer、Allergan、LEO...Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash.In 2018, the global Dermatitis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatitis Drugs. This study researches the market size of Dermatitis Drugs, presents the global Dermatitis Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界のパラフェニルフェノール産業：成長傾向・競合分析2019-2025
    DATA909X01707 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のパラフェニルフェノール市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。パラフェニルフェノールの種類別には、純度≥99％、純度...The Para Phenyl Phenol market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Para Phenyl Phenol. This study focuses on the production side and consumption side of Para Phenyl Phenol, presents the global Para Phenyl Phenol market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. In...
  • 世界の4-フェニルフェノール産業：成長傾向・競合分析2019-2025
    DATA909X00029 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の4-フェニルフェノール市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。4-フェニルフェノールの種類別には、純度≥99％、純度...The 4-Phenylphenol market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for 4-Phenylphenol. This study focuses on the production side and consumption side of 4-Phenylphenol, presents the global 4-Phenylphenol market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. In terms of production side, this report researches the...

    • ◆H&Iグローバルリサーチのお客様（例）◆